Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers
Use of Resveratrol to Decrease Secondary Brain Injury Following Sports-Related Concussions: a Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers
Use of Resveratrol to Decrease Secondary Brain Injury Following Sports-Related Concussions: a Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
A Prospective, Phase 4, Open-Label, Twelve-Week Study to Examine the Cognitive Impact and Tolerability of Levetiracetam (Keppra) in Elderly Patients With Seizures of Partial Onset
Status: Enrolling
Updated:  12/31/1969
Drexel University College of Medicine, Dept of Neurology
mi
from
Philadelphia, PA
Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
A Prospective, Phase 4, Open-Label, Twelve-Week Study to Examine the Cognitive Impact and Tolerability of Levetiracetam (Keppra) in Elderly Patients With Seizures of Partial Onset
Status: Enrolling
Updated: 12/31/1969
Drexel University College of Medicine, Dept of Neurology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke: A Phase II Clinical Trial.
Status: Enrolling
Updated:  12/31/1969
St. John's Rehab; Sunnybrook Health Sciences Centre
mi
from
Toronto,
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke: A Phase II Clinical Trial.
Status: Enrolling
Updated: 12/31/1969
St. John's Rehab; Sunnybrook Health Sciences Centre
mi
from
Toronto,
Click here to add this to my saved trials
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke: A Phase II Clinical Trial.
Status: Enrolling
Updated:  12/31/1969
Rehabilitation Institute of St. Louis
mi
from
Saint Louis, MO
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke
Exploring the Efficacy of Combined Task-Specific and Cognitive Strategy Training in Subacute Stroke: A Phase II Clinical Trial.
Status: Enrolling
Updated: 12/31/1969
Rehabilitation Institute of St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Status: Enrolling
Updated:  12/31/1969
Riley Child & Adolescent Psychiatry Clinic- Riley Hospital
mi
from
Indianapolis, IN
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Status: Enrolling
Updated: 12/31/1969
Riley Child & Adolescent Psychiatry Clinic- Riley Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Status: Enrolling
Updated:  12/31/1969
Lurie Center - MassGeneral Hospital
mi
from
Lexington, MA
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Status: Enrolling
Updated: 12/31/1969
Lurie Center - MassGeneral Hospital
mi
from
Lexington, MA
Click here to add this to my saved trials
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical System
mi
from
Baltimore, MD
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Status: Enrolling
Updated:  12/31/1969
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Status: Enrolling
Updated: 12/31/1969
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Status: Enrolling
Updated:  12/31/1969
Kernan Hospital
mi
from
Baltimore, MD
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
Status: Enrolling
Updated: 12/31/1969
Kernan Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Spaeth/Richman Contrast Sensitivity Test
Validation and Reproducibility of Spaeth/Richman Contrast Sensitivity Test
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Spaeth/Richman Contrast Sensitivity Test
Validation and Reproducibility of Spaeth/Richman Contrast Sensitivity Test
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Arcadia, CA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Arcadia, CA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
La Jolla, CA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Westminster, CO
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Westminster, CO
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
DeLand, FL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jupiter, FL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Plantation, FL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plantation, FL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Port Orange, FL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bloomington, IL
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bloomington, IL
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Evansville, IN
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Leawood, KA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Leawood, KA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Watertown, MA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Watertown, MA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Altoona, PA
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Altoona, PA
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A 52-Week, Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
MEG and DTI of Neural Function and Connectivity in Traumatic Brain Injury
Magnetoencephalography and High-Field Diffusion Tensor Magnetic Resonance Imaging of Neural Function and Connectivity in Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
San Francisco General Hospital
mi
from
San Francisco, CA
MEG and DTI of Neural Function and Connectivity in Traumatic Brain Injury
Magnetoencephalography and High-Field Diffusion Tensor Magnetic Resonance Imaging of Neural Function and Connectivity in Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
Mercy Gilbert and Chandler Medical Center
mi
from
Gilbert, AZ
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
Mercy Gilbert and Chandler Medical Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
University of California Irvine Department of Neurology
mi
from
Orange, CA
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
University of California Irvine Department of Neurology
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke
Status: Enrolling
Updated:  12/31/1969
University of California San Diego Division of Neurological Surgery
mi
from
San Diego, CA
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke
Status: Enrolling
Updated: 12/31/1969
University of California San Diego Division of Neurological Surgery
mi
from
San Diego, CA
Click here to add this to my saved trials
Structural and Functional Neuroimaging Studies of Combat Veterans
Structural and Functional Neuroimaging Studies of Combat Veterans
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Structural and Functional Neuroimaging Studies of Combat Veterans
Structural and Functional Neuroimaging Studies of Combat Veterans
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
PRX-00023 Therapy in Localization-Related Epilepsy
A Phase II Clinical Trial of PRX-00023 Therapy in Localization-Related Epilepsy
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
PRX-00023 Therapy in Localization-Related Epilepsy
A Phase II Clinical Trial of PRX-00023 Therapy in Localization-Related Epilepsy
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Aging and Estrogen on Cortical Function
The Effect of Low Dose Estrogen on Cortical Function as a Function of Age in Postmenopausal Women.
Status: Enrolling
Updated:  12/31/1969
Reproductive Endocrine Unit, Massachusetts General Hospital
mi
from
Boston, MA
Aging and Estrogen on Cortical Function
The Effect of Low Dose Estrogen on Cortical Function as a Function of Age in Postmenopausal Women.
Status: Enrolling
Updated: 12/31/1969
Reproductive Endocrine Unit, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial
A Randomized Trial of CT-guided Perineural Injection With a Corticosteroid Plus a Long Acting Local Anesthetic Versus Standard Medical Management in Patients With Acute Lumbar Radiculopathy and a Corresponding Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial
A Randomized Trial of CT-guided Perineural Injection With a Corticosteroid Plus a Long Acting Local Anesthetic Versus Standard Medical Management in Patients With Acute Lumbar Radiculopathy and a Corresponding Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Phase I/II Trial of Dasatinib (Sprycel) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
Status: Enrolling
Updated:  12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Phase I/II Trial of Dasatinib (Sprycel) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
Status: Enrolling
Updated: 12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Eslicarbazepine Acetate Monotherapy Long Term Study
Long Term Eslicarbazepine Acetate Extension Study
Status: Enrolling
Updated:  12/31/1969
Neurology Clinic PC
mi
from
Northport, AL
Eslicarbazepine Acetate Monotherapy Long Term Study
Long Term Eslicarbazepine Acetate Extension Study
Status: Enrolling
Updated: 12/31/1969
Neurology Clinic PC
mi
from
Northport, AL
Click here to add this to my saved trials
Eslicarbazepine Acetate Monotherapy Long Term Study
Long Term Eslicarbazepine Acetate Extension Study
Status: Enrolling
Updated:  12/31/1969
21st Century Neurology, a division of Xenoscience, Inc.
mi
from
Phoenix, AZ
Eslicarbazepine Acetate Monotherapy Long Term Study
Long Term Eslicarbazepine Acetate Extension Study
Status: Enrolling
Updated: 12/31/1969
21st Century Neurology, a division of Xenoscience, Inc.
mi
from
Phoenix, AZ
Click here to add this to my saved trials